Precision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue Estimates

Precision BioSciences (DTIL) came out with a quarterly loss of $3.20 per share versus the Zacks Consensus Estimate of a loss of$ 0.42. This compares to loss of $3.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -661.90%. A quarter ago, it was expected that this genome editing company would post a loss of$ 0.79 per share when it actually produced a loss of $2.83, delivering a surprise of -258.23%.Over the last four quarters, ...